TY - CHAP
T1 - Microbiome
T2 - A Key Regulator of Body-Brain Interactions
AU - O’Riordan, Kenneth J.
AU - Aburto, Maria R.
AU - Nagpal, Jatin
AU - Clarke, Gerard
AU - Cryan, John F.
N1 - Publisher Copyright:
© The Author(s), under exclusive license to Springer Nature Switzerland AG 2025.
PY - 2025
Y1 - 2025
N2 - The gut microbiota, consisting of trillions of microorganisms, plays a critical role in regulating host physiology, including metabolism, immune responses, and brain function. This chapter examines the microbiota-gut-brain axis, a multifaceted bidirectional communication system connecting gut microbial activity with central nervous system processes through immune pathways, metabolic byproducts, and neural circuits like the vagus nerve. The evolution of the gut microbiota throughout an individual’s life—from early developmental influences like birth mode and antibiotic use to changes associated with aging and neurodegenerative conditions—highlights its dynamic nature. The chapter reviews experimental approaches and microbiome-based interventions to demonstrate the influence of gut microbiota on neurological conditions such as autism spectrum disorder, anxiety, and Alzheimer’s disease. Finally, it emphasises the importance of advancing microbiome-targeted therapies, integrating emerging technologies, and clinical trials to develop personalised strategies for enhancing brain health through gut microbiome modulation.
AB - The gut microbiota, consisting of trillions of microorganisms, plays a critical role in regulating host physiology, including metabolism, immune responses, and brain function. This chapter examines the microbiota-gut-brain axis, a multifaceted bidirectional communication system connecting gut microbial activity with central nervous system processes through immune pathways, metabolic byproducts, and neural circuits like the vagus nerve. The evolution of the gut microbiota throughout an individual’s life—from early developmental influences like birth mode and antibiotic use to changes associated with aging and neurodegenerative conditions—highlights its dynamic nature. The chapter reviews experimental approaches and microbiome-based interventions to demonstrate the influence of gut microbiota on neurological conditions such as autism spectrum disorder, anxiety, and Alzheimer’s disease. Finally, it emphasises the importance of advancing microbiome-targeted therapies, integrating emerging technologies, and clinical trials to develop personalised strategies for enhancing brain health through gut microbiome modulation.
KW - Blood-Brain Barrier (BBB)
KW - Gut Microbiota
KW - Microbiota-Gut-Brain Axis
KW - Neurodevelopment
KW - Neuroinflammation
KW - Psychobiotics
KW - Short-Chain Fatty Acids (SCFAs)
KW - Vagus Nerve
UR - https://www.scopus.com/pages/publications/105007366516
U2 - 10.1007/978-3-031-89525-8_6
DO - 10.1007/978-3-031-89525-8_6
M3 - Chapter
C2 - 40442386
AN - SCOPUS:105007366516
T3 - Advances in Experimental Medicine and Biology
SP - 139
EP - 203
BT - Advances in Experimental Medicine and Biology
PB - Springer
ER -